mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0005 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |